Clinical trial

Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world Conditions

NCT07052396

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Dupilumab Normalized identity: dupilumabView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world Conditions

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-07-01

PhaseN/A

Conditions

Chronic Obstructive Pulmonary Disease (COPD)verified · MONDO: chronic obstructive pulmonary disease

Interventions

DupilumabDRUG · verified · RxNorm: dupilumab

Sponsors & collaborators

Sanofilead sponsor

Regeneron Pharmaceuticalscollaborator

Mapped research locations

BerlinGermany2 HamburgGermany2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07052396 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.